Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based 177Lu-DOTATATE treatment of NET patients
Titel:
Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based 177Lu-DOTATATE treatment of NET patients
Auteur:
Sundlöv, Anna Gleisner, Katarina Sjögreen Tennvall, Jan Ljungberg, Michael Warfvinge, Carl Fredrik Holgersson, Kajsa Hallqvist, Andreas Bernhardt, Peter Svensson, Johanna
Verschenen in:
European journal of nuclear medicine and molecular imaging